PCCA Science is at the forefront of compounding research and development. Yi Liu, PhD, a PCCA research pharmacist, walks us through a few recent and exciting developments from the PCCA Science division.

June has some exciting guests including: Sara Hover, RPh and Deborah Clark, BSPharm, RPh, both from PCCA's Clinical Compounding group. Sara joined Seb and Mike to talk about how compounders can help with autoimmune disorders and Deborah discussed compounding for the veterinary world. Those topics, and so much more, are waiting for you on the latest episodes of The Mortar & Pestle.

Periorbital hyperpigmentation is caused by various external and internal factors, which makes it very complex to treat, but PCCA's Sara Hover, RPh, FAARM, discusses treatment options unique to personalized medicine that may help compounding pharmacies treat patients with this skin disorder.

Every month, there are new scientific publications involving PCCA products or services. These publications include journal articles, conference abstracts, conference posters, technical reports and case studies. Maria Carvalho , PharmD, MRPharmS, PhD, is the Manager of PCCA Science, she dives into some of the exciting updates for compounders.

PCCA's own Ranel Larsen of Clinical Services gives the low-down on our HRT Symposium. She has lots to say about how compounders use HRT to help patients around the globe. "It is the compounding industry’s biggest hormone replacement event," she says, "And this year was no exception.."

In recognition of National Autism Awareness Month, Tricia Heitman of PCCA's clinical services team, discusses ways in which compounders help families and patients work to manage the obstacles autism presents.

The experts in our Clinical Services and Formulation Development departments recommend Lipoderm as a first choice for customized transdermal medications. Here’s why.

Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.

Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.

PCCA's own Sebastian Denison to speak on the LDN Radio Show on February 20th, at 3 p.m. CT!